# Surmasis Pharmaceutical, LLC – FDA Inspection, Mar 1, 2018

Source: https://www.keypedia.com/records/fda_inspections/surmasis-pharmaceutical-llc/e05262f6-17af-45f8-8849-59e1059d8573
Source feed: FDA_Inspections

> FDA inspection 1042777 of Surmasis Pharmaceutical, LLC, March 01, 2018. Classification: Official Action Indicated (OAI). 5 citations under 21 CFR part 211. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1042777
- Company Name: Surmasis Pharmaceutical, LLC
- Inspection Date: 2018-03-01
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Generic Drug Evaluation
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 5

## Related Documents

- [FDA Inspection 1277270 - 2025-08-01](https://www.keypedia.com/records/fda_inspections/surmasis-pharmaceutical-llc/5fb29e39-e823-41b8-9d3c-db716adf874c)
- FDA Inspection 1121169 - 2020-03-19

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/brett-r-havranek/6a4eaba0-a8df-40f6-a21d-45ec5a0e9f6b)
- [FDA Associated Person](https://www.keypedia.com/people/michele-l-obert/7ac8155e-cc5a-4e89-a885-c68ce69adb4e)

Company: https://www.keypedia.com/companies/surmasis-pharmaceutical-llc/6f9dfe3c-c8c3-4740-b9a8-0ecc1bb9b400

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c